TMO · NYSE
Thermo Fisher Scientific Inc.
$673.82 -3.02 (-0.45%)
Company overview
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bioproduction to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Exchange
- NYSE
- Market cap
- $249B
- Employees
- 125,000
- Headquarters
- Waltham, MA
- Website
- thermofisher.com
- CEO
- Marc N. Casper
- Listed
- March 17, 1980
- P/E
- 36.98
- Dividend yield
- 0.29%
Company financials
- Revenue
- $45.2B
- Gross profit
- $17.8B
- Operating income
- $8B
- EBITDA
- $11.2B
- Net income
- $6.9B
- EPS
- $18.22
- Total assets
- $113B
- Total debt
- $43.2B
- Gross margin
- 39.41%
- Net margin
- 15.18%
- Earnings yield
- 2.70%
Showing FY 2025
TMO
1D
NYSE
O691.70H703.20L674.10C676.54-17.48 (-2.52%)Vol3.60M